Abstract
Risk factors for increased risk of death from Coronavirus Disease 19 (COVID-19) have been identified1,2 but less is known on characteristics that make communities resilient or vulnerable to the mortality impacts of the pandemic. We applied a two-stage Bayesian spatial model to quantify inequalities in excess mortality at the community level during the first wave of the pandemic in England. We used geocoded data on all deaths in people aged 40 years and older during March-May 2020 compared with 2015-2019 in 6,791 local communities. Here we show that communities with an increased risk of excess mortality had a high density of care homes, and/or high proportion of residents on income support, living in overcrowded homes and/or high percent of people with a non-White ethnicity (including Black, Asian and other minority ethnic groups). Conversely, after accounting for other community characteristics, we found no association between population density or air pollution and excess mortality. Overall, the social and environmental variables accounted for around 15% of the variation in mortality at community level. Effective and timely public health and healthcare measures that target the communities at greatest risk are urgently needed if England and other industrialised countries are to avoid further widening of inequalities in mortality patterns during the second wave.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
P.E. is Director of the UK Small Area Health Statistics Unit. He acknowledges support from the Medical Research Council (MRC) for the MRC Centre for Environment and Health (MR/S019669/1), the British Heart Foundation Imperial College Centre for Research Excellence (RE/18/4/34215), National Institute for Health Research (NIHR) Imperial College Biomedical Research Centre (BRC), the NIHR Health Protection Research Unit (HPRU) on Environmental Exposures and Health (NIHR-200880), and the NIHR HPRU in Chemical and Radiation Threats and Hazards (NIHR-200922). P.E. is supported by Health Data Research UK (HDR UK) and the UK Dementia Research Institute at Imperial College London, which receives funding from the UK Medical Research Council, Alzheimers Society and Alzheimers Research UK (MC_PC_17114). P.E. also acknowledges support from the Huo Family Foundation for research into COVID-19. J.B. and M.E are supported by Pathways to Equitable Healthy Cities grant from the Wellcome Trust (209376/Z/17/Z). B.D acknowledges funding from the NIHR HPRU in Chemical and Radiation Threats and Hazards (NIHR-200922) and the HDR UK Hub DISCOVER-NOW. All authors acknowledge infrastructure support for the Department of Epidemiology and Biostatistics provided by the NIHR Imperial BRC. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was covered by national research ethics approval from the London-South East Research Ethics Committee (Reference 17/LO/0846). Data access was covered by the Health Research Authority Confidentiality Advisory Group under section 251 of the National Health Service Act 2006 and the Health Service (Control of Patient Information) Regulations 2002 (Reference 20/CAG/0008).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data availability: No identifiable information will be shared with any other organisation. SAHSU does not have permission to supply data to third parties. Individual mortality data can be requested through the Office for National Statistics (https://www.ons.gov.uk/). Mid-year population estimates can be downloaded from https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/datasets/middlesuperoutputareamidyearpopulationestimates. English Index of Multiple Deprivation data can be downloaded from https://www.gov.uk/government/statistics/english-indices-of-deprivation-2019. 2011 Census data can be downloaded from https://www.ons.gov.uk/census/2011census/2011censusdata. Modelled air pollution data (NO2 & PM2.5) can be downloaded from https://uk-air.defra.gov.uk/data/pcm-data. Locations data of care homes can be downloaded from https://covid19.esriuk.com/datasets/e4ffa672880a4facaab717dea3cdc404_0. Code availability: The computer code written in R51 for the two stages of Bayesian models used in this work is available on request.
https://www.gov.uk/government/statistics/english-indices-of-deprivation-2019
https://www.ons.gov.uk/census/2011census/2011censusdata
https://uk-air.defra.gov.uk/data/pcm-data
https://covid19.esriuk.com/datasets/e4ffa672880a4facaab717dea3cdc404_0
